Human in vivo competitive inhibition of P450 substrates: increased plasma concentrations as a function of hepatic extraction ratio and percent inhibition.

Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Société canadienne des sciences pharmaceutiques

Volumn 2, Issue 3, 1999, Pages 89-91

  Boxenbaum, H ^a  

^a Arishel Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLARITHROMYCIN; CYP3A PROTEIN, HUMAN; CYTOCHROME P450; ENZYME INHIBITOR; KETOCONAZOLE; MIXED FUNCTION OXIDASE; TRIAZOLAM;

ARTICLE; BINDING COMPETITION; BLOOD; DRUG ANTAGONISM; DRUG EFFECT; HUMAN; LIVER; METABOLISM;

BINDING, COMPETITIVE; CLARITHROMYCIN; CYTOCHROME P-450 ENZYME SYSTEM; ENZYME INHIBITORS; HUMANS; KETOCONAZOLE; LIVER; MIXED FUNCTION OXYGENASES; TRIAZOLAM;

EID: 0033185953     PISSN: None     EISSN: 14821826     Source Type: Journal    
DOI: None     Document Type: Article

References (0)